MedKoo Cat#: 526285 | Name: Sch 24518

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sch 24518 is a D1 receptor antagonist.

Chemical Structure

Sch 24518
Sch 24518
CAS#90955-43-4

Theoretical Analysis

MedKoo Cat#: 526285

Name: Sch 24518

CAS#: 90955-43-4

Chemical Formula: C16H16ClNO

Exact Mass: 273.0920

Molecular Weight: 273.76

Elemental Analysis: C, 70.20; H, 5.89; Cl, 12.95; N, 5.12; O, 5.84

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Sch 24518; Sch24518; Sch-24518.
IUPAC/Chemical Name
8-Chloro-2,3,4,5-tetrahydro-5-phenyl-1H-3-benzazepin-7-ol
InChi Key
InChi Code
SMILES Code
OC1=C(Cl)C=C2CCNCC(C3=CC=CC=C3)C2=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 273.76 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Yang ZY, Perry B, Mukherjee J. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors. Nucl Med Biol. 1996 Aug;23(6):793-805. PubMed PMID: 8940723. 2: Rinne JO, Laihinen A, Någren K, Bergman J, Solin O, Haaparanta M, Ruotsalainen U, Rinne UK. PET demonstrates different behaviour of striatal dopamine D-1 and D-2 receptors in early Parkinson's disease. J Neurosci Res. 1990 Dec;27(4):494-9. PubMed PMID: 1981915. 3: Ram S, Ehrenkaufer RE, Spicer LD. Synthesis of the labeled D1 receptor antagonist SCH 23390 using [11C]carbon dioxide. Int J Rad Appl Instrum A. 1989;40(5):425-7. PubMed PMID: 2548974. 4: Adam MJ, Grierson JR, Jivan S. An improved HPLC system for the analysis and purification of organic amine radiopharmaceuticals. Int J Rad Appl Instrum A. 1989;40(1):91-2. PubMed PMID: 2540126. 5: DeJesus OT, Van Moffaert GJ, Friedman AM. Synthesis of [11C]SCH 23390 for dopamine D1 receptor studies. Int J Rad Appl Instrum A. 1987;38(5):345-8. PubMed PMID: 3038787. 6: Halldin C, Stone-Elander S, Farde L, Ehrin E, Fasth KJ, Långström B, Sedvall G. Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors using positron emission tomography. Int J Rad Appl Instrum A. 1986;37(10):1039-43. PubMed PMID: 3027000.